The importance of diversity in clinical trials for hepatitis C
The importance of diversity in clinical trials for hepatitis C
Aja McCutchen, MD, does a deep dive into why hepatitis C seems to disproportionately affect Black people. She explains the importance of diversity in clinical trials due to genetic, metabolic, social, economic, and cultural factors.
Up next
The importance of diversity in clinical trials for hepatitis C
Jan 20, 2026
Facing stigma as a Black hepatitis C patient
Jan 20, 2026
Seeking hepatitis C treatment as a young patient of color
Jan 20, 2026
Asking questions & accessing resources as a woman of color with hepatitis C
Jan 20, 2026
Seeking out a doctor of color as a hepatitis C patient
Jan 20, 2026
How blood transfusions for sickle cell may have impacted hepatitis C rates among Black Americans
Jan 20, 2026
Treatment advancements for hepatitis C
Jan 20, 2026
Seeking accessible healthcare for the Black community: one woman's journey from homelessness to hepatitis C survivor
Jan 20, 2026
3 ways to overcome hepatitis C stigma
Dec 4, 2019
Facing the stigma of a hepatitis C diagnosis
Jan 20, 2026
Taking care of hepatitis C now and looking toward the future
Jan 20, 2026
Recommended for you
How can I be more consistent?